Speech-Language Pathologists in Grafton, WI Accepting Medicare

6 Speech-Language Pathologists found. Showing 1 - 6

Mrs. Michelle A Chopp, M.S., CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1775 Oneida Ct, Grafton, WI 53024 Phone: 262-376-0414

Ms. Caitlin Lindsay Ebel, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 975 Port Washington Rd, Grafton, WI 53024 Phone: 262-329-2700

Ms. Erin Marie Dzwinel, MS,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 908 2nd Ave, Grafton, WI 53024 Phone: 414-899-5798

Kimberly Harrison, M.A.CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 101 Falls Rd, Suite 403, Grafton, WI 53024 Phone: 414-559-0050    Fax: 262-421-8681

Caitlin Marie Hill, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 975 Port Washington Rd, Grafton, WI 53024 Phone: 262-329-2700

Angela Haendel, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1172 Knollwood Dr, Grafton, WI 53024 Phone: 414-526-5335

News Archive

Regular use of common pain relief medicines improves survival for head and neck cancer patients

Regular use of a common type of medication, such as aspirin and ibuprofen, significantly improves survival for a third or more patients with head and neck cancer, a new study led by UC San Francisco has found.

VertiFlex enrolls 100 patients in Superion Interspinous Spacer IDE clinical trial

VertiFlex, Inc., a leading innovator of minimally invasive and motion preserving spinal surgery technologies, today announced that 100 patients have been enrolled in its pivotal IDE clinical trial of the Superion Interspinous Spacer (ISS).

Study: Extended azithromycin therapy may offer significant benefits to COPD patients

Extended use of a common antibiotic may prolong the time between hospitalizations for patients suffering from chronic obstructive pulmonary disease, according to a post-hoc analysis of a multicenter study which compared the hospitalization rates of patients treated with a 12-month course of azithromycin to the rates of those treated with placebo.

New tool can help doctors identify patients at highest risk for respiratory failure after surgery

A new prediction tool can help doctors better identify patients who are at highest risk for respiratory failure after surgery and therefore prevent the often deadly condition, suggest data from a large multi-center study published in the May issue of Anesthesiology.

Read more Medical News

› Verified 8 days ago